Intellia Therapeutics Inc (NASDAQ:NTLA)
| 37.59 Delayed Data As of 4:00pm ET |  +1.57 / +4.36%Today’s Change | 32.44 Today|||52-Week Range 78.58 | +7.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 75.8M | 273.1M | 340.7M | 314.1M | |
| Short Term Investment Cash | 66.0M | 197.2M | 67.6M | -281.8M | ||
| Cash & Short Term Investments | 75.8M | 273.1M | 340.7M | 314.1M | ||
| Receivables | Receivables | 1.0M | 6.5M | 10.5M | 7.5M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 810.0K | 1.8M | 3.7M | 3.4M | |
| Current Assets | 77.6M | 281.3M | 354.8M | 325.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 3.0M | 12.1M | 19.6M | 25.7M | |
| Depreciation | -331.0K | -1.4M | -4.3M | -8.6M | ||
| Other Assets | 1.8M | 7.0M | 6.1M | 5.3M | ||
| Total Assets | 82.1M | 299.0M | 376.2M | 347.3M | ||
| Liabilities | Accounts Payable | 1.4M | 4.7M | 2.2M | 2.7M | |
| Accrued Expenses | 1.5M | 3.2M | 3.2M | 4.6M | ||
| Other Current Liabilities | 8.1M | 23.4M | 24.4M | 31.7M | ||
| Other Liabilities | 10.7M | 30.7M | 31.4M | 40.6M | ||
| Total Liabilities | Other Liabilities | 323.0K | 293.0K | 168.0K | 13.0K | |
| Total Liabilities | 14.8M | 89.1M | 75.6M | 69.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 88.6M | 0.00 | 0.00 | 0.00 | ||
| Common Equity | -21.2M | 209.8M | 300.6M | 277.9M | ||
| Total Shareholder Equity | 67.4M | 209.8M | 300.6M | 277.9M | ||
| Share Information | Common Shares Outstanding | 36.0M | 36.0M | 42.4M | 45.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
